| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-602
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
2002-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b40d96f73fa6fcf7e2125cbb7fa16b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0db99efa541d3167572b8ca82312479
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f6dc72c0f94a96c4d503d30ab9baa80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47e985d6ac5455e4cdce02dec08c3753
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0beafba71c747eee1173f34167c60283
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81334283ceef1f07bf7ee1ae62aad766
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20144e6160709e4f32891ca06efdf499 |
| publicationDate |
2004-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004242499-A1 |
| titleOfInvention |
Novel galactosylceramide analogs, and beta-glucocerebrosidase activators, external skin preparations and method of activating beta-glucocerebrosidase using the analogs |
| abstract |
Galactosylceramide analogues represented by the following formula (1) or (2). n n n (wherein X and Y each represent S or O, R 1 and R 2 each represent an alkyl group or an alkenyl group each having 9 to 35 carbon atoms. R 3 represents an alkyl group or an alkenyl group each having 2 to 30 carbon atoms.) n It is provided a β-glucocerebrosidase activator which is easily available, and external skin preparations and a method of activating β-glucocerebrosidase, in which improvement in formation of horny layer transmission barrier is expected by activating β-glucocerebrosidase so that an improved effect in rough skin is also expected. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10709758-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10933126-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017207040-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014053482-A1 |
| priorityDate |
2001-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |